Varamir
Desk
News
Calendar
Pricing
Saved
Search
tickers or companies
⌘K
Start free
· no card
Sign in
ASND compared with BCAX: revenue, margins and what each company keeps, and the suppliers and customers both name
ASND
Ascendis Pharma A/S
Change
Mkt cap
Revenue
Revenue
BCAX
Bicara Therapeutics Inc.
Change
Mkt cap
Revenue
Revenue
vs
Compare
ASND
Ascendis Pharma A/S
vs
BCAX
Bicara Therapeutics Inc.
Price
Mkt cap
Revenue
Revenue
Change
Change
Revenue flow
Supply chain
Price
Co-movers
Event sensitivity
Earnings history
Save comparison
Copy link
Revenue flow
Desk
News
Calendar
Saved
Search
Revenue flow
Supply chain
Price
Co-movers
Event sensitivity
Earnings history
Price
rebased to 0%
1D
1W
1M
3M
YTD
1Y
5Y
1D
1W
1M
3M
YTD
1Y
5Y
ASND, solid
BCAX, dashed
Supply-chain overlap
Revenue flow
ASND: latest quarter not drawable. BCAX: latest quarter not drawable.
Method
›
ASND
Ascendis Pharma A/S
Change
252.96
▼
−0.02%
· post 251.31
Mkt cap
$15.6B
BCAX
Bicara Therapeutics Inc.
Change
9.11
▼
−6.38%
· post 8.91
Closed
Oct 30 '26
Mkt cap
$620.2M
vs
Compare
Closed
Oct 30 '26
ASND
Ascendis Pharma A/S
vs
BCAX
Bicara Therapeutics Inc.
252.96
▼
−0.02%
post 251.31
Price
9.11
▼
−6.38%
post 8.91
$15.6B
Mkt cap
$620.2M
Change
Change
ASND
252.96
▼
−0.02%
vs
BCAX
9.11
▼
−6.38%
Closed
Oct 30 '26
Supply-chain overlap
direct ties · both sides
Sources
›
direct ties · both sides
Only ASND
3
NVO
Novo Nordisk A/S
customer
—
Teijin
unlisted
customer
—
VISEN Pharmaceuticals
unlisted
customer
Shared
0
No shared counterparties.
Only BCAX
2
MSD
MSD International GmbH and MSD International Business GmbH
supplier
—
Biocon
unlisted
supplier
Role chip = supplier or customer
—
= no ticker (unlisted)
Source: SEC EDGAR